Crispr enzymes and systems with modified pam specificity
US-2026071198-A1 · Mar 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
Zetsche Bernd patents
Zetsche Bernd is listed as an inventor on 84 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Zetsche Bernd |
| Total patents | 84 |
| First publication | Jul 21, 2016 |
| Latest publication | Mar 12, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for treating hemoglobinopathies
US-2026061041-A1 · Mar 5, 2026 · US
CRISPR having or associated with destabilization domains
US-12435320-B2 · Oct 7, 2025 · US
CRISPR enzymes and systems
US-12410468-B2 · Sep 9, 2025 · US
CRISPR enzymes and systems with modified pam specificity
US-12410416-B2 · Sep 9, 2025 · US
Crispr enzymes and systems
US-2025250617-A1 · Aug 7, 2025 · US
Crispr enzymes and systems
US-2025250618-A1 · Aug 7, 2025 · US
CRISPR enzymes and systems
US-12371737-B2 · Jul 29, 2025 · US
Novel crispr enzymes and systems
US-2025215425-A1 · Jul 3, 2025 · US
CPF1 complexes with reduced indel activity
US-12344838-B2 · Jul 1, 2025 · US
Recent patents
Latest publications not already listed above.
Crispr enzyme mutations reducing off-target effects
US-2025179453-A1 · Jun 5, 2025 · US
CRISPR enzymes and systems
US-12264359-B2 · Apr 1, 2025 · US
CIRCULAR GUIDE RNAs FOR CRISPR/CAS EDITING SYSTEMS
US-2024376468-A1 · Nov 14, 2024 · US
CRISPR enzyme mutations reducing off-target effects
US-12123032-B2 · Oct 22, 2024 · US
CRISPR enzymes and systems
US-12110490-B2 · Oct 8, 2024 · US
Crispr enzymes, methods, systems and uses thereof
US-2024327813-A1 · Oct 3, 2024 · US
Crispr enzymes and systems
US-12091709-B2 · Sep 17, 2024 · US
Compositions and methods for treating hemoglobinopathies
US-12016908-B2 · Jun 25, 2024 · US
Novel crispr enzymes, methods, systems and uses thereof
US-2024167008-A1 · May 23, 2024 · US
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
US-2024132867-A1 · Apr 25, 2024 · US
Crispr enzymes and systems
US-2024084364-A1 · Mar 14, 2024 · US
Systems, methods, and compositions for targeted nucleic acid editing
US-2024076651-A1 · Mar 7, 2024 · US
Crystal structure of crispr cpf1
US-2024035006-A1 · Feb 1, 2024 · US
Systems, methods, and compositions for targeted nucleic acid editing
US-11866697-B2 · Jan 9, 2024 · US
Crispr enzymes and systems
US-11781172-B2 · Oct 10, 2023 · US
CRISPR enzymes and systems
US-11773432-B2 · Oct 3, 2023 · US
Compositions and methods for treating hemoglobinopathies
US-11752202-B2 · Sep 12, 2023 · US
Novel crispr enzymes, methods, systems and uses thereof
US-2023279373-A1 · Sep 7, 2023 · US
Cas12b systems, methods, and compositions for targeted dna base editing
US-2023193242-A1 · Jun 22, 2023 · US
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
US-2023140953-A1 · May 11, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Broad Inst Inc | 62 |
| Massachusetts Inst Technology | 61 |
| Harvard College | 34 |
| Beam Therapeutics Inc | 23 |
| Zhang Feng | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N9/22 | 84 |
| C12N2310/20 | 75 |
| C12N15/11 | 55 |
| C12N15/113 | 54 |
| C12N15/102 | 54 |